Pfizer says bivalent booster increases antibodies for Omicron variants
2 years, 2 months ago

Pfizer says bivalent booster increases antibodies for Omicron variants

LA Times  

Pfizer Inc. and its German vaccine partner BioNTech said their new COVID-19 booster designed to target the dominant Omicron subvariant produced more antibodies against the intended strains than did the original version of the shot. Pfizer and BioNTech plan to release additional data on the COVID-19 shots in the coming weeks to measure immune responses one month after administration of the new bivalent booster, which also targets the original coronavirus strain. “While we expect more mature immune-response data from the clinical trial of our Omicron BA.4/BA.5-adapted bivalent vaccine in the coming weeks, we are pleased to see encouraging responses just one week after vaccination in younger and older adults,” Pfizer Chief Executive Albert Bourla said in the statement. “These early data suggest that our bivalent vaccine is anticipated to provide better protection against currently circulating variants than the original vaccine, and potentially help to curb future surges in cases this winter.” The vaccine partners studied two cohorts that had been given the new vaccine: one comprised those ages 18 to 55, the other those 55 and up.

History of this topic

FDA advisers urge targeting JN.1 strain in recipe for fall’s COVID vaccines
6 months, 2 weeks ago
New COVID-19 vaccines available in Australia: Millions urged to get a booster as cases rise
1 year ago
What To Know About New COVID Boosters And Who Is Eligible
1 year, 3 months ago
US FDA authorizes Pfizer-BioNTech, Moderna's updated Covid shots
1 year, 3 months ago
CBS News poll finds less concern about new COVID variants now than with Omicron
1 year, 3 months ago
U.S. approves updated COVID vaccines to rev up protection this fall
1 year, 3 months ago
US approves updated COVID vaccines to rev up protection this fall
1 year, 3 months ago
Should you get the new COVID booster? The CDC is about to decide
1 year, 3 months ago
FDA approves updated COVID vaccines to rev up protection this fall
1 year, 3 months ago
FDA vaccine adviser Dr Paul Offit says healthy young people don't need another Covid booster - despite new BA.2.86 variant pushing virus rates up
1 year, 3 months ago
Moderna says updated COVID vaccine is effective against ‘highly-mutated’ BA.2.86 variant
1 year, 3 months ago
Next round of COVID-19 shots in fall will target latest omicron strain
1 year, 6 months ago
FDA advisers endorse updating COVID vaccines to target latest omicron strain
1 year, 6 months ago
COVID vaccine should be updated to target XBB strain, FDA committee says
1 year, 6 months ago
An FDA panel meets about which COVID strains the U.S. will target with vaccines
1 year, 6 months ago
FDA advisers back updated COVID shots for fall vaccinations
1 year, 6 months ago
Extra COVID-19 booster now open to some high-risk Americans
1 year, 8 months ago
CDC signs off on additional Covid-19 booster doses for certain people
1 year, 8 months ago
Extra spring COVID booster cleared for certain Americans
1 year, 8 months ago
Pfizer Bivalent Vaccine Reduces Covid-related Death Risk by 68 Pc in Older People: Study
1 year, 8 months ago
The COVID virus has mutated so much since 2019 that some experts say it should be renamed SARS-CoV-3
1 year, 8 months ago
No need for booster vaccine against coronavirus this spring, experts decide
1 year, 9 months ago
No need for booster vaccine against coronavirus this spring, experts decide
1 year, 9 months ago
Protein-based booster shots help fight Omicron
1 year, 10 months ago
Australian adults will be able to get fifth dose of COVID-19 vaccine later this month
1 year, 10 months ago
FDA advisers set to consider one-and-done annual covid booster plan
1 year, 10 months ago
FDA’s advisors back plan to simplify COVID-19 vaccinations
1 year, 10 months ago
FDA proposes once-a-year COVID-19 shots for most Americans
1 year, 11 months ago
FDA vaccine advisers ‘disappointed’ and ‘angry’ that early data about new Covid-19 booster shot wasn’t presented for review last year
1 year, 11 months ago
India Saw Over 294 Omicron Variants in 2022, Not One Could Survive Here; Booster Shot Wise Call: INSACOG Co-Chair
1 year, 11 months ago
First real-world data show Omicron booster kept seniors out of hospitals
1 year, 11 months ago
'Consider 2nd Booster': A Request Given to Mansukh Mandaviya During Covid-19 Meeting with Doctors
1 year, 11 months ago
Omicron boosters for the youngest children are here. Will they make a difference?
1 year, 11 months ago
New Omicron sub-variant is mild: Doctors
2 years ago
Your Best Shot at Fighting Covid: 28% Have Already Taken Booster Dose, Finds Survey
2 years ago
COVID-19: no need for scaremongering, precautions needed, say health experts
2 years ago
FDA clears updated COVID-19 vaccines for kids under age 5
2 years ago
Pfizer asks FDA to clear updated COVID shot for kids under 5
2 years ago
As COVID-19 spikes in California, booster shots could make all the difference
2 years ago
US renews push for COVID boosters as data show they protect
2 years, 1 month ago
Pfizer booster spurs immune response to new Omicron subvariants
2 years, 1 month ago
Pfizer study says updated COVID boosters rev up antibody protection
2 years, 1 month ago
New Omicron Variants Not Causing Significant Rise in Hospitalisations, Say Experts
2 years, 1 month ago
How Pfizer plans to sell its Covid vaccine back to YOU with a 10,000% markup
2 years, 1 month ago
New bivalent Covid vaccines DON'T give people better immunity, studies show
2 years, 1 month ago
Covid booster shot campaign opens to everyone 12 and up
2 years, 1 month ago
Covid boosters available to everyone in their thirties and older
2 years, 2 months ago
EMA gives positive advice over Covid-19 vaccines for children from 6 months
2 years, 2 months ago
Updated COVID boosters are now available for kids. Here’s how to get them
2 years, 2 months ago

Discover Related